
Selected top pharmaceutical R&D projects based on net present value (NPV) as of May 2021 (in million U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Projection of top global pharmaceutical products by revenue growth 2022
- Top new orphan molecular entities by U.S. sales in 2019
- Top U.S. proton pump inhibitors' revenue market share 2013
- Top U.S. cholesterol-lowering drugs by revenue market share 2013
- Count of first-time medtech approvals granted by FDA 2006-2017
- Revenue of top 20 respiratory brands in the U.S. 2016
- Italy: number of biotech orphan drugs drugs marketed 2016-2017, by type
- Italy: number of biotech projects along the drug pipeline 2016-2017, by area
- Size comparison of small-moelcule drugs and biologics 2020
- Top U.S. proton pump inhibitors based on prescriptions 2013
- Novartis's biggest sales growth drivers by change in sales 2019-2026
- Greece: pharmaceutical products export value 2020, by type
- Global women's health drugs and devices market share by application 2016 and 2023
- Global women's health drugs and devices market 2016 and 2023
- Leading traditional therapy areas by unit cost change U.S. 2019
Evaluate. (July 30, 2021). Selected top pharmaceutical R&D projects based on net present value (NPV) as of May 2021 (in million U.S. dollars) [Graph]. In Statista. Retrieved May 22, 2022, from https://www.statista.com/statistics/309464/major-pharmaceutical-randd-projects-based-on-net-present-value/
Evaluate. "Selected top pharmaceutical R&D projects based on net present value (NPV) as of May 2021 (in million U.S. dollars)." Chart. July 30, 2021. Statista. Accessed May 22, 2022. https://www.statista.com/statistics/309464/major-pharmaceutical-randd-projects-based-on-net-present-value/
Evaluate. (2021). Selected top pharmaceutical R&D projects based on net present value (NPV) as of May 2021 (in million U.S. dollars). Statista. Statista Inc.. Accessed: May 22, 2022. https://www.statista.com/statistics/309464/major-pharmaceutical-randd-projects-based-on-net-present-value/
Evaluate. "Selected Top Pharmaceutical R&d Projects Based on Net Present Value (Npv) as of May 2021 (in Million U.S. Dollars)." Statista, Statista Inc., 30 Jul 2021, https://www.statista.com/statistics/309464/major-pharmaceutical-randd-projects-based-on-net-present-value/
Evaluate, Selected top pharmaceutical R&D projects based on net present value (NPV) as of May 2021 (in million U.S. dollars) Statista, https://www.statista.com/statistics/309464/major-pharmaceutical-randd-projects-based-on-net-present-value/ (last visited May 22, 2022)